{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:37:58Z","timestamp":1790350678510,"version":"4.1.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1097\/mbc.0b013e32822d2a3c","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T22:44:38Z","timestamp":1236206678000},"page":"589-593","source":"Crossref","is-referenced-by-count":40,"title":["Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review"],"prefix":"10.1097","volume":"18","author":[{"given":"Massimo","family":"Franchini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Manzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luca","family":"Salvagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210203","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM199908193410807","article-title":"Disseminated intravascular coagulation","volume":"341","author":"Levi","year":"1999","journal-title":"N Engl J Med"},{"key":"R2-1-20210203","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1055\/s-0037-1615899","article-title":"Disseminated intravascular coagulation: state of the art","volume":"82","author":"Levi","year":"1999","journal-title":"Thromb Haemost"},{"key":"R3-1-20210203","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0268-960X(02)00032-2","article-title":"The diagnosis of disseminated intravascular coagulation","volume":"16","author":"Levi","year":"2002","journal-title":"Blood Rev"},{"key":"R4-1-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-9560-4-4","article-title":"Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation","volume":"4","author":"Franchini","year":"2006","journal-title":"Thromb J"},{"key":"R5-1-20210203","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1160\/TH03-03-0182","article-title":"Coagulation of sepsis","volume":"91","author":"Dempfle","year":"2004","journal-title":"Thromb Haemost"},{"key":"R6-1-20210203","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1055\/s-2001-18864","article-title":"Disseminated intravascular coagulation in trauma patients","volume":"27","author":"Gando","year":"2001","journal-title":"Semin Thromb Hemost"},{"key":"R7-1-20210203","first-page":"172","article-title":"Disseminated intravascular coagulation due to malignancy","volume":"17","author":"Colman","year":"1990","journal-title":"Semin Oncol"},{"key":"R8-1-20210203","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000046585","article-title":"Pathogenetic mechanisms of thrombosis in malignancy","volume":"106","author":"Donati","year":"2001","journal-title":"Acta Haematol"},{"key":"R9-1-20210203","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1055\/s-2001-18865","article-title":"Disseminated intravascular coagulation in acute leukemia","volume":"27","author":"Barbui","year":"2001","journal-title":"Semin Thromb Hemost"},{"key":"R10-1-20210203","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1053\/beog.2001.0204","article-title":"Disseminated intravascular coagulation","volume":"4","author":"Letsky","year":"2001","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R11-1-20210203","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0037-1963(01)90140-4","article-title":"The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis","volume":"38","author":"Hoffman","year":"2001","journal-title":"Semin Hematol"},{"key":"R12-1-20210203","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1046\/j.1538-7836.2003.00225.x","article-title":"Mechanism of action of recombinant factor VIIa","volume":"1","author":"Lisman","year":"2003","journal-title":"J Thromb Haemost"},{"key":"R13-1-20210203","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1172\/JCI116691","article-title":"The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor","volume":"92","author":"ten Cate","year":"1993","journal-title":"J Clin Invest"},{"key":"R14-1-20210203","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1365-2141.2001.02878.x","article-title":"Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII","volume":"113","author":"Moscardo","year":"2001","journal-title":"Br J Haematol"},{"key":"R15-1-20210203","first-page":"21","article-title":"Efficacy of recombinant activated factor VII (rFVIIa,NovoSeven\u00ae) in prenatal medicine","volume":"8","author":"Breborowicz","year":"2002","journal-title":"Arch Perinat Med"},{"key":"R16-1-20210203","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000064699","article-title":"Successful use of recombinant factor VIIa for massive bleeding after caesarean section due to HELLP syndrome","volume":"108","author":"Zupancic","year":"2002","journal-title":"Acta Haematol"},{"issue":"Suppl","key":"R17-1-20210203","first-page":"155","article-title":"Recombinant factor VIIa (rFVIIa) is effective at massive bleeding after cesarean section \u2013 a case report","volume":"26","author":"Sokolic","year":"2002","journal-title":"Coll Antropol"},{"key":"R18-1-20210203","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00101-003-0482-2","article-title":"Pathophysiological and therapeutic aspects of amniotic fluid embolism (anaphylactoid syndrome of pregnancy): case report with lethal outcome and overview","volume":"52","author":"Kretzschmar","year":"2003","journal-title":"Anaesthesist"},{"key":"R19-1-20210203","first-page":"1174","article-title":"Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII","volume":"101","author":"Bouwmeester","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R20-1-20210203","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijgo.2004.08.007","article-title":"Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy","volume":"87","author":"Lim","year":"2004","journal-title":"Int J Gynecol Obstet"},{"key":"R21-1-20210203","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.annfar.2004.09.005","article-title":"Recombinant activated factor VII as a life-saving therapy for severe postpartum haemorrhage unresponsive to conservative traditional management","volume":"23","author":"Brice","year":"2004","journal-title":"Ann Fr Anesth Reanim"},{"key":"R22-1-20210203","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1471-0528.2004.00058.x","article-title":"Prolonged treatment of massive postpartum haemorrhage with recombinant factor VIIa: case report and review of the literature","volume":"111","author":"Boehlen","year":"2004","journal-title":"Br J Obstet Gynaecol"},{"key":"R23-1-20210203","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.0001-6349.2004.00501.x","article-title":"The use of recombinant factor VIIa in severe postpartum hemorrhage","volume":"83","author":"Segal","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R24-1-20210203","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/bja\/aeh196","article-title":"Use of recombinant factor VIIa to treat life-threatening nonsurgical bleeding in a postpartum patient","volume":"93","author":"Price","year":"2004","journal-title":"Br J Anaesth"},{"key":"R25-1-20210203","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1080\/01443610400019120","article-title":"Caesarean section for placenta praevia complicated by postpartum haemorrhage managed successfully with recombinant activated human coagulation factor VIIa","volume":"24","author":"Gidiri","year":"2004","journal-title":"J Obstet Gynaecol"},{"key":"R26-1-20210203","first-page":"144","article-title":"Successful treatment of severe postpartum bleeding after caesarean section using recombinant activated factor VII","volume":"70","author":"Holub","year":"2005","journal-title":"Ces Gynek"},{"key":"R27-1-20210203","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.AOG.0000197064.44340.d4","article-title":"Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation","volume":"108","author":"Pepas","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R28-1-20210203","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1080\/00016340600855839","article-title":"Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use","volume":"85","author":"Sobieszczyk","year":"2006","journal-title":"Acta Obstet Gynecol"},{"key":"R29-1-20210203","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0140-6736(99)05155-7","article-title":"Treatment of traumatic bleeding with recombinant factor VIIa","volume":"354","author":"Kenet","year":"1999","journal-title":"Lancet"},{"key":"R30-1-20210203","first-page":"431","article-title":"Recombinant activated factor VII for adjunctive hemorrhage control in trauma","volume":"51","author":"Martinowitz","year":"2001","journal-title":"J Trauma"},{"key":"R31-1-20210203","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0149-7944(02)00690-6","article-title":"Use of recombinant FVIIa for intraperitoneal coagulopathic bleeding in a septic patient","volume":"60","author":"Holcomb","year":"2003","journal-title":"Curr Surg"},{"key":"R32-1-20210203","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.mbc.0000169224.23550.3f","article-title":"Treatment of intra-abdominal bleeding with recombinant activated factor VII in a patient with disseminated intravascular coagulation secondary to septic shock","volume":"16","author":"Martinez","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R33-1-20210203","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/01.mbc.0000220245.20036.2d","article-title":"The use of recombinant activated factor VII in the treatement of massive pulmonary hemorrhage in a preterm infant","volume":"17","author":"Cetin","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"Suppl 1","key":"R34-1-20210203","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1097\/00001721-200004001-00019","article-title":"Recombinant activated factor VII in children with acute bleeding resulting from liver failure and disseminated intravascular coagulation","volume":"11","author":"Chuansumrit","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R35-1-20210203","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00001721-200406000-00008","article-title":"The use of recombinant activated factor VII for controlling life-threatening bleeding in Dengue Shock Syndrome","volume":"15","author":"Chuansumrit","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R36-1-20210203","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/gast.2002.34164","article-title":"Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy","volume":"123","author":"Jeffers","year":"2002","journal-title":"Gastroenterology"},{"key":"R37-1-20210203","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/01.mpa.0000158026.30925.b4","article-title":"Use of recombinant activated factor VII for bleeding in pancreatitis. A case series","volume":"30","author":"Laffan","year":"2005","journal-title":"Pancreas"},{"key":"R38-1-20210203","first-page":"577","article-title":"Recombinant activated factor VII in patients with cancer and hemorrhagic disseminated intravascular coagulation","volume":"15","author":"Sallah","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R39-1-20210203","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1600-0609.2004.00237.x","article-title":"Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia","volume":"72","author":"Zver","year":"2004","journal-title":"Eur J Haematol"},{"key":"R40-1-20210203","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/j.1537-2995.2005.00548.x","article-title":"A multicenter assessment of recombinant factor VIIa off-label usage: clinical experiences and associated outcomes","volume":"45","author":"MacLaren","year":"2005","journal-title":"Transfusion"},{"key":"R41-1-20210203","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.curobgyn.2003.12.004","article-title":"Massive postpartum hemorrhage and management of disseminated intravascular coagulation","volume":"14","author":"Macphail","year":"2004","journal-title":"Curr Obstetr Gynaecol"},{"key":"R42-1-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc4828","article-title":"Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding \u2013 a European perspective","volume":"10","author":"Vincent","year":"2006","journal-title":"Crit Care"},{"key":"R43-1-20210203","doi-asserted-by":"crossref","first-page":"S241","DOI":"10.1007\/s00134-002-1471-7","article-title":"Updates in the management of severe coagulopathy in trauma patients","volume":"28","author":"Lynn","year":"2002","journal-title":"Intensive Care Med"},{"key":"R44-1-20210203","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1097\/01.TA.0000169871.29748.95","article-title":"Use of recombinant activated factor VII to treat the acquired coagulopathy of trauma","volume":"58","author":"Holcomb","year":"2005","journal-title":"J Trauma"},{"key":"R45-1-20210203","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.20123","article-title":"Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: a break from convention in need of controlled trials","volume":"39","author":"Caldwell","year":"2004","journal-title":"Hepatology"},{"key":"R46-1-20210203","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jama.295.3.293","article-title":"Thromboembolic adverse events after use of recombinant human coagulation factor VIIa","volume":"295","author":"O'Connell","year":"2006","journal-title":"JAMA"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00001721-200710000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:08:26Z","timestamp":1618034906000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-200710000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e32822d2a3c","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}